Skip to content

High Intensity Interval Training (HIIT) In Overweight And Obese Class I Psychiatric Patients

Effect Of High Intensity Interval Training (HIIT) In Overweight And Obese Class I Psychiatric Patients - An Experimental Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014891
Enrollment
32
Registered
2018-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F99- Mental disorder, not otherwise specified Health Condition 2: null- OVERWEIGHT AND OBESE CLASS I PSYCHIATRY INDIVIDUALS

Interventions

Intervention1: SINGLE GROUP: 5-10 MINUTES OF WARM UP SESSION. HIIT WILL BE GIVEN FOR 1 MINUTE AND 1 MINUTE REST WILL BE GIVE. A TOTAL OF 20 MINUTES OF PROTOCOL WITH 10 MINUTES OF HIIT AND 10 MINUTES O

Sponsors

KAHER INSTITUTE OF PHYSIOTHERAPY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects willing to participate in the study. Both male and female subjects between the age group of 19-50 years. Diagnosed from any psychiatric disorder by a psychiatrist. BMI between 25 to 34.99 kg/m2. Patients who are able to follow commands.

Exclusion criteria

Exclusion criteria: Subjects having any cardiovascular or respiratory disorders. Any congenital, malignant, autoimmune, and neurological conditions (apart from psychiatric illness). Subjects undergoing electro-convulsive therapy. Subjects whose CK values fall in the normal criteria i.e. 52 - 336 U/L for Male gender and for all age groups, 38 - 176U/L for Female gender and for all age groups.

Design outcomes

Primary

MeasureTime frame
TOTAL CHOLESTROL FASTING BLOOD GLUCOSE SERUM CREATINE PHOSPHOKINASE BODY COMPOSITION ANALYZER SF-36 QUALITY OF LIFE QUESTIONNAIRETimepoint: AT THE BEGINNING AND AT THE END OF THE INTERVENTION. (TWO TIMES)

Secondary

MeasureTime frame
TOTAL CHOLESTROL FASTING BLOOD GLUCOSE SERUM CREATINE PHOSPHOKINASE BODY COMPOSITION ANALYZER SF-36 QUALITY OF LIFE QUESTIONNAIRETimepoint: AT THE BEGINNING AND AT THE END OF THE INTERVENTION. (TWO TIMES)

Countries

India

Contacts

Public ContactFARHANA BOOTWALA

KAHER INSTITUTE OF PHYSIOTHERAPY

sanjiv3303@rediffmail.com9448745648

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026